(Q80188566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Treatment of active secondary progressive multiple sclerosis with treosulfan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

secondary progressive multiple sclerosis

29 December 2019

main subject

0 references

author

Heinz Wiendl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Robert Weissert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Wilhelm Kuker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Bernd C Kieseier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Heidrun A Mylius

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Uwe Pichlmeier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hans-Peter Hartung

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Arthur Melms

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michael Weller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

20 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

884-889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17446994%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-006-0459-6

29 December 2019

exact match

0 references

1 reference

12 December 2020

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

12 December 2020

Myeloablative and immunosuppressive properties of treosulfan in mice

1 reference

12 December 2020

Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.

1 reference

12 December 2020

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force

1 reference

12 December 2020